CA-125 glycovariant assays enhance diagnostic sensitivity in the detection of epithelial ovarian cancer
This is the first study describing the clinical performance of GLYVAR Ovarian I and II assays in ovarian cancer diagnostics. The results indicate that the CA-125 glycovariant assays have remarkable potential to improve ovarian cancer diagnostics.
Authors
- Sabine Kasimir‐Bauer (ORCID: https://orcid.org/0000-0002-8081-1799)
- Paul Buderath (ORCID: https://orcid.org/0000-0003-0941-5635)
- Kaisa Huhtinen (ORCID: https://orcid.org/0000-0001-9685-5246)
- Rainer Kimmig (ORCID: https://orcid.org/0000-0003-1118-2199)
- Stefanos Ioannis Moukas (ORCID: https://orcid.org/0009-0006-1695-0985)
- Katri Kuningas
- M Helle
- Leena Kokko
Institutions
- University of Turku (FI)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1515/cclm-2025-0561
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00